Allied Healthcare Products, Inc.
Other OTCTotal Valuation
Allied Healthcare Products, Inc. carries a market capitalization of 4,010.00, placing it among publicly traded companies globally. Its enterprise value stands at 5.70M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 4,010.00 |
| Enterprise Value | 5.70M |
Share Statistics
Allied Healthcare Products, Inc. currently has 4.01M shares outstanding.
| Shares Outstanding | 4.01M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Allied Healthcare Products, Inc. trades at a trailing price-to-earnings ratio of 24.25. The price-to-sales ratio is 0.24, and the price-to-book ratio stands at -0.29.
| PE Ratio | 24.25 |
| PS Ratio | 0.24 |
| PB Ratio | -0.29 |
| P/TBV Ratio | 1.25 |
| P/FCF Ratio | -1.60 |
| P/OCF Ratio | -1.60 |
Enterprise Valuation
| EV / Sales | 0.21 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Financial Position
Allied Healthcare Products, Inc. maintains a current ratio of 2.69, meaning it holds 2.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 47.28, indicating elevated leverage, while an interest coverage ratio of -21.57 demonstrates limited ability to service its debt obligations.
| Current Ratio | 2.69 |
| Quick Ratio | 0.95 |
| Debt / Equity | 47.28 |
| Debt / EBITDA | -0.60 |
| Interest Coverage | -21.57 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -28.69 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.74 |
Taxes
| Income Tax | 599,672.00 |
| Effective Tax Rate | N/A |
Income Statement
Over the trailing twelve months, Allied Healthcare Products, Inc. generated 27.05M in revenue and converted that into -5.36M in net income, yielding earnings per share of -1.34. EBITDA reached -4.13M, while operating income came in at -4.58M.
| Revenue | 27.05M |
| Gross Profit | 2.53M |
| Operating Income | -4.58M |
| Pretax Income | -4.76M |
| Net Income | -5.36M |
| EBITDA | -4.13M |
| EBIT | -4.58M |
| Earnings Per Share (EPS) | -1.34 |
Balance Sheet
Allied Healthcare Products, Inc. holds 3.32M in cash and equivalents against 2.47M in total debt, resulting in a net debt position of -850,687.00. Total book value stands at -22.31M, with working capital of 10.10M providing operational flexibility.
| Cash & Cash Equivalents | 3.32M |
| Total Debt | 2.47M |
| Net Debt | -850,687.00 |
| Equity (Book Value) | -22.31M |
| Book Value Per Share | -5.56 |
| Working Capital | 10.10M |
Cash Flow
Allied Healthcare Products, Inc. produced -4.10M in operating cash flow over the past twelve months.
| Operating Cash Flow | -4.10M |
| Capital Expenditures | N/A |
| Free Cash Flow | -4.10M |
| FCF Per Share | -1.02 |
Margins
Allied Healthcare Products, Inc. operates with a gross margin of 9.34, reflecting its pricing power and cost economics. The operating margin of -16.93 and net profit margin of -19.82 provide insight into operational efficiency.
| Gross Margin | 9.34 |
| Operating Margin | -16.93 |
| Pretax Margin | -17.61 |
| Profit Margin | -19.82 |
| EBITDA Margin | -15.27 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -129.80 |
| FCF Yield | -62.62 |
Stock Splits
Allied Healthcare Products, Inc.'s most recent stock split took place on December 7, 2016 with a 2:1 split ratio.
| Last Split Date | 12/7/2016 |
| Split Ratio | 2:1 |
Scores
Allied Healthcare Products, Inc. posts an Altman Z-Score of -0.10, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -0.10 |